China Touts Improvements in Postmarket Monitoring of Medical Devices

The Chinese government describes its nationwide system for monitoring medical device-related adverse events, the State Food and Drug Administration (SFDA) in a recently released white paper. Ten national centers are responsible for registration-related testing of domestic Class III devices and imported devices. Another 30 centers at the provincial level are responsible for sample testing devices within their jurisdictions and for registration testing of certain medical devices, the report says.